- Home
- KROS vs SSYS Comparison
KROS vs SSYS Comparison
Compare KROS & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- SSYS
- Stock Information
- Founded
- KROS 2015
- SSYS 1989
- Country
- KROS United States
- SSYS United States
- Employees
- KROS N/A
- SSYS N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- KROS Health Care
- SSYS Technology
- Exchange
- KROS Nasdaq
- SSYS Nasdaq
- Market Cap
- KROS 558.9M
- SSYS 857.2M
- IPO Year
- KROS 2020
- SSYS 1994
- Fundamental
- Price
- KROS $14.53
- SSYS $11.18
- Analyst Decision
- KROS Buy
- SSYS Strong Buy
- Analyst Count
- KROS 13
- SSYS 4
- Target Price
- KROS $20.63
- SSYS $12.50
- AVG Volume (30 Days)
- KROS 487.4K
- SSYS 425.0K
- Earning Date
- KROS 08-06-2025
- SSYS 08-28-2025
- Dividend Yield
- KROS N/A
- SSYS N/A
- EPS Growth
- KROS N/A
- SSYS N/A
- EPS
- KROS 0.11
- SSYS N/A
- Revenue
- KROS $214,713,000.00
- SSYS $564,454,000.00
- Revenue This Year
- KROS $5,006.76
- SSYS $2.01
- Revenue Next Year
- KROS N/A
- SSYS $4.01
- P/E Ratio
- KROS $132.53
- SSYS N/A
- Revenue Growth
- KROS 91657.70
- SSYS N/A
- 52 Week Low
- KROS $9.12
- SSYS $6.05
- 52 Week High
- KROS $72.37
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- SSYS 53.25
- Support Level
- KROS $13.26
- SSYS $10.63
- Resistance Level
- KROS $14.68
- SSYS $11.90
- Average True Range (ATR)
- KROS 0.41
- SSYS 0.34
- MACD
- KROS 0.12
- SSYS 0.01
- Stochastic Oscillator
- KROS 89.35
- SSYS 56.89
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.